Hydrogen chloride-ethyl acetate → N-{[(6S,7R)-7-(4-chloro-3-fluorophenyl)-1,4-oxazepan-6-yl]methyl}-2-ethoxyacetamide monohydrochloride

HRID 1022629

Reaktionsgleichung

Reaktionsgleichung von HRID 1022629
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]2[O:14][CH2:13][CH2:12][N:11](C(OC(C)(C)C)=O)[CH2:10][C@H:9]2[CH2:22][NH:23][C:24](=[O:29])[CH2:25][O:26][CH2:27][CH3:28])=[CH:4][C:3]=1[F:30].C(OCC)(=O)C.Cl>>[ClH:1].[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]2[O:14][CH2:13][CH2:12][NH:11][CH2:10][C@H:9]2[CH2:22][NH:23][C:24](=[O:29])[CH2:25][O:26][CH2:27][CH3:28])=[CH:4][C:3]=1[F:30]

Komponenten

3

Edukt 2

HCID 21866389Hydrogen chloride-ethyl acetateHCID 66975262tert-butyl (6R,7R)-7-(4-chloro-3-fluorophenyl)-6-{[(ethoxyacetyl)amino]methyl}-1,4-oxazepane-4-carboxylate

Produkt 1

HCID 66976374N-{[(6S,7R)-7-(4-chloro-3-fluorophenyl)-1,4-oxazepan-6-yl]methyl}-2-ethoxyacetamide monohydrochlorideAusbeute 171,8 %

Versuchsvorschrift

To tert-butyl (6R,7R)-7-(4-chloro-3-fluorophenyl)-6-{[(ethoxyacetyl)amino]methyl}-1,4-oxazepane-4-carboxylate (125 mg) was added 4.0 M hydrogen chloride-ethyl acetate solution (2.11 ml), and the mixture was stirred at room temperature for 1 hr. The residue obtained by concentration under reduced pressure was recrystallized from ethanol-diisopropyl ether to give the title compound (92.0 mg).

Aufarbeitung

  1. customThe residue obtained by concentration under reduced pressure
  2. customwas recrystallized from ethanol-diisopropyl ether

Quellen und Nachweise

ORD-Eintrag
ord-2a9423b9a2cb4120a6f3414c61625d8d
Quelldatensatz
uspto-grants-2014_05
Patentnummer
US08722662B2

Verknüpfte Notizen

Wird geladen…